Overall rank by patents
#39,995
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01J (MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY).
The verdict
EPIR holds 6 US patents across 6 technology areas, rank #39,995 of 50,000 tracked assignees.
EPIR, Inc. has been granted 6 US utility patents between 2022 and 2025, placing EPIR, Inc. at rank #39,995 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.2 claims per patent with primary concentration in G01J (MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY). As a US Corporation, EPIR, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, EPIR sits between EPED, Inc. (6 patents, rank #39,991) and Equi-nom Ltd (6 patents, rank #39,999) - the closest US assignees by grant volume. The composite Innovation Score of 42.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 6 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. EPIR, Inc.'s 12.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark EPIR, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
EPED, Inc.
6 patents
EPICMEMS(XIAMEN) CO., LTD.
6 patents
EPICS THERAPEUTICS
6 patents
EPIGEN Biosciences, Inc.
6 patents
EPISYS SCIENCE, INC.
6 patents
EPL LIMITED
6 patents
EPtronics, Inc.
6 patents
EQUI-NOM LTD
6 patents
EPIR, INC.
6 patents
What this shows EPIR holds 6 patents at rank #39,995, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #39,995 in granted patent volume.
Other assignees with the most granted patents in EPIR's primary technology class.
EPIR's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
43 Top 30% higher than 70% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 1 | 16.7% |
| 2023 | 2 | 33.3% |
| 2024 | 2 | 33.3% |
| 2025 | 1 | 16.7% |
Top 6 of 6 technology areas
Overall rank by patents
#39,995
Across all tracked assignees
42.7 out of 100
How to use this portfolio
EPIR's 6 grants land it in the top 30% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.